These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 17174517)

  • 1. Prognostic factors and outcome in women with uterine sarcoma.
    Denschlag D; Masoud I; Stanimir G; Gilbert L
    Eur J Surg Oncol; 2007 Feb; 33(1):91-5. PubMed ID: 17174517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients.
    Bodner K; Bodner-Adler B; Obermair A; Windbichler G; Petru E; Mayerhofer S; Czerwenka K; Leodolter S; Kainz C; Mayerhofer K
    Gynecol Oncol; 2001 May; 81(2):160-5. PubMed ID: 11330943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis of 105 cases with uterine sarcoma.
    Yoney A; Eren B; Eskici S; Salman A; Unsal M
    Bull Cancer; 2008 Mar; 95(3):E10-7. PubMed ID: 18390406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
    Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
    Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.
    Burghaus S; Halmen S; Gass P; Mehlhorn G; Schrauder MG; Lux MP; Renner SP; Beckmann MW; Hein A; Thiel FC
    Arch Gynecol Obstet; 2016 Aug; 294(2):343-51. PubMed ID: 26711836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study.
    Schick U; Bolukbasi Y; Thariat J; Abdah-Bortnyak R; Kuten A; Igdem S; Caglar H; Ozsaran Z; Lössl K; Schleicher U; Zwahlen D; Villette S; Vees H
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e757-63. PubMed ID: 22300565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical review of 97 patients with endometrial stromal sarcoma].
    Li N; Wu LY; Zhang HT; An JS; Li XG; Ma SK
    Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):115-9. PubMed ID: 18683750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery and adjuvant radiation therapy of endometrial stromal sarcoma.
    Weitmann HD; Kucera H; Knocke TH; Pötter R
    Wien Klin Wochenschr; 2002 Jan; 114(1-2):44-9. PubMed ID: 12407935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial stromal sarcomas--a retrospective analysis of 11 patients.
    Diesing D; Cordes T; Finas D; Löning M; Mayer K; Diedrich K; Friedrich M
    Anticancer Res; 2006; 26(1B):655-61. PubMed ID: 16739335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
    Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
    Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression.
    Geller MA; Argenta P; Bradley W; Dusenbery KE; Brooker D; Downs LS; Judson PL; Carson LF; Boente MP
    Gynecol Oncol; 2004 Dec; 95(3):632-6. PubMed ID: 15581975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A clinical analysis of 153 uterine sarcomas].
    Bai P; Sun J; Chao H
    Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):163-7. PubMed ID: 9596892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment options in stage I endometrial stromal sarcoma: a retrospective analysis of 53 cases.
    Li N; Wu LY; Zhang HT; An JS; Li XG; Ma SK
    Gynecol Oncol; 2008 Feb; 108(2):306-11. PubMed ID: 18061249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial stromal sarcoma: a population-based analysis.
    Chan JK; Kawar NM; Shin JY; Osann K; Chen LM; Powell CB; Kapp DS
    Br J Cancer; 2008 Oct; 99(8):1210-5. PubMed ID: 18813312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival?
    Garg G; Shah JP; Toy EP; Bryant CS; Kumar S; Morris RT
    Gynecol Oncol; 2010 Jul; 118(1):8-13. PubMed ID: 20447684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcoma of the prostate: a single institutional review.
    Janet NL; May AW; Akins RS
    Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).
    Reed NS; Mangioni C; Malmström H; Scarfone G; Poveda A; Pecorelli S; Tateo S; Franchi M; Jobsen JJ; Coens C; Teodorovic I; Vergote I; Vermorken JB;
    Eur J Cancer; 2008 Apr; 44(6):808-18. PubMed ID: 18378136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-institutional review of outcomes of endometrial stromal sarcoma.
    Leath CA; Huh WK; Hyde J; Cohn DE; Resnick KE; Taylor NP; Powell MA; Mutch DG; Bradley WH; Geller MA; Argenta PA; Gold MA
    Gynecol Oncol; 2007 Jun; 105(3):630-4. PubMed ID: 17320937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and treatment-related outcome in patients with uterine papillary serous carcinoma.
    Sagr ER; Denschlag D; Kerim-Dikeni A; Stanimir G; Gitsch G; Gilbert L
    Anticancer Res; 2007; 27(2):1213-7. PubMed ID: 17465265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial stromal sarcoma: analysis of treatment failures and survival.
    Gadducci A; Sartori E; Landoni F; Zola P; Maggino T; Urgesi A; Lissoni A; Losa G; Fanucchi A
    Gynecol Oncol; 1996 Nov; 63(2):247-53. PubMed ID: 8910635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.